New Drug Targets in Rheumatoid Arthritis: Focus on Chemokines

ISSN： 1173-8804

Source： BioDrugs, Vol.18, Iss.3, 2004-01, pp. : 181-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Therapeutic Approaches to the Management of Rheumatoid Arthritis

By Hughes L.B. Moreland L.W.

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 379-393

Adis International

Access to resources Recommend Favorite

Cyclosporin in Rheumatoid Arthritis: Monitoring for Adverse Effects and Clinically Significant Drug Interactions

By Dijkmans B. Gerards A.

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 437-445

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Rheumatoid Arthritis This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in Drugs 2002; 62 (17): 2493-2537.

By Culy C.R. Keating G.M.

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 139-145

Adis International

Access to resources Recommend Favorite

Rituximab: In Rheumatoid Arthritis

By Frampton James E. Scott Lesley J.

BioDrugs, Vol. 21, Iss. 5, 2007-01 ,pp. : 333-341

Adis International

Access to resources Recommend Favorite

Abatacept for rheumatoid arthritis

By Rojahn Ruth

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 456-457

Blackwell Publishing

Access to resources Recommend Favorite